Scholarlink

<p>Bone marrow adipose tissue (BMAT) is an important modulator of metabolic and skeletal homeostasis in obesity. This review summarises current evidence supporting mechanistic links between BMAT and the development and progression of obesity. Accumulating data indicate that, beyond serving as a distinct adipose depot, BMAT functions as a dynamic and adaptive regulator within the bone marrow (BM) microenvironment under obese conditions. Therefore, limiting BM adipogenesis, regulating BMAT-derived adipokines, reversing metabolic dysfunction, and modulating systemic energy homeostasis have been proposed as potential therapeutic strategies for obesity. Collectively, BMAT is a previously underappreciated yet promising target for tailored, mechanism-based therapeutic strategies in obesity. Future research should prioritise mechanistic dissection and clinical validation of BMAT-targeted strategies, together with improved imaging and quantitative methodologies and Traditional Chinese Medicine (TCM)-informed system-level regulatory approaches, to facilitate their translation into effective therapies for obesity and related metabolic disorders.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bone marrow adipose tissue in obesity: a previously underappreciated but promising therapeutic target

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月3日

查看全文
  • Hai Long Yu,
  • Rui Chen,
  • Suwen Sun,
  • Ruixian Zhou

摘要

Bone marrow adipose tissue (BMAT) is an important modulator of metabolic and skeletal homeostasis in obesity. This review summarises current evidence supporting mechanistic links between BMAT and the development and progression of obesity. Accumulating data indicate that, beyond serving as a distinct adipose depot, BMAT functions as a dynamic and adaptive regulator within the bone marrow (BM) microenvironment under obese conditions. Therefore, limiting BM adipogenesis, regulating BMAT-derived adipokines, reversing metabolic dysfunction, and modulating systemic energy homeostasis have been proposed as potential therapeutic strategies for obesity. Collectively, BMAT is a previously underappreciated yet promising target for tailored, mechanism-based therapeutic strategies in obesity. Future research should prioritise mechanistic dissection and clinical validation of BMAT-targeted strategies, together with improved imaging and quantitative methodologies and Traditional Chinese Medicine (TCM)-informed system-level regulatory approaches, to facilitate their translation into effective therapies for obesity and related metabolic disorders.